Overview
Lung cancer screening is a controversial preventive measure in the medical community. Screening for lung cancer involves the use of computed tomography (CT) scans to detect early signs of the disease to provide preventive care. While this procedure can potentially provide early detection and treatment of the disease, it can also misdiagnose healthy individuals resulting in unnecessary anxiety and follow-up procedures. Additionally, the radiation associated with the scan can pose risks for patients. Despite the potential drawbacks, screening for lung cancer may reduce mortality rates. For individuals at high risk for lung cancer, screening is recommended by the U.S. Preventive Services Task Force. The American Cancer Society also recommends CT scans for adults aged 55 to 74 who are current or former smokers. Overall, there is still ongoing research to further investigate the potential benefits, risks, and costs associated with lung cancer screening.